Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.8/5
Alphamab Co Ltd (9966 HK)
Watchlist
Contact IR
121
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
09 Jun 2024 02:05
Hong Kong Connect Flows (Jun 7th): China Mobile, Tencent, BOC, China Hongqiao, Yankuang Energy
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for China Mobile, Tencent, BOC, China Hongqiao, Yankuang Energy.
Ke Yan, CFA, FRM
Follow
453 Views
Share
bullish
•
Quantitative Analysis
•
02 Jun 2024 02:05
Hong Kong Connect Flows (May 31st): BOC, CNOOC, ABC, Xiaomi, Petrochina
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for BOC, CNOOC, Agricultural Bank Of China, Xiaomi Corporation,...
Ke Yan, CFA, FRM
Follow
765 Views
Share
bullish
•
Quantitative Analysis
•
31 Mar 2024 02:05
Hong Kong Connect Flows (Mar 28th): Tencent, Bank Of China, China Mobile, Xiaomi, CNOOC
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Bank Of China, China Mobile, Xiaomi, CNOOC.
Ke Yan, CFA, FRM
Follow
551 Views
Share
bullish
•
Akeso Biopharma Inc
•
20 Mar 2024 10:39
Akeso Inc Placement - A Small One to Digest, Momentum Has Been Strong
Akeso Biopharma Inc (9926 HK) is looking to raise US$155m from its primary placement. Representing 5.7 days of its three month ADV, the deal would...
Clarence Chu
Follow
516 Views
Share
bearish
•
Quantitative Analysis
•
28 Jan 2024 02:20
Hong Kong Connect Flows (Jan 26th): Tencent
We analyzed southbound Hong Kong connect flows in the past week and highlight southbound Hong Kong connect flows for Tencent.
Ke Yan, CFA, FRM
Follow
470 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x